Boston Scientific announced it will begin a new Plavix Compliance program aimed at helping patients with drug eluting stents stick with the full duration of their prescription for the dual anti-platelet inhibitors. Plavix has been identified by physicians and the FDA as a leading factor in preventing late stent thrombosis. Ninety-five percent of patients with insurance or Medicare receive full coverage for their Plavix prescriptions.

Cordis' Regatta Steerable Guide wire has a unique micro-ridge design and enhanced Torque Response at the tip. Micro-ridge tapers from the round central core into the flat portion and minimizes twisting in the flat region, therefore enhancing torque control. A gradual transition of the ridge minimizes prolapse.

Dr. Nabil Dib, M.D., M.Sc., director of Cardiovascular Cell Therapy at University of California San Diego, reported how 23 patients in an FDA trial were safely transformed from advanced heart failure to recovery, during ACC 2007.

Results of the COURAGE trial are unlikely to alter the approach that interventional cardiologists take in treating most patients with chronic stable angina, say leaders from the Society for Cardiovascular Angiography and Interventions (SCAI).

March 29, 2007 — Results of the COURAGE trial, presented today at the American College of Cardiology Annual Scientific Session, are unlikely to alter the approach that interventional cardiologists take in treating most patients with chronic stable angina, say leaders from the Society for Cardiovascular Angiography and Interventions (SCAI), the leading professional society for interventional cardiologists in the United States.

March 29, 2007 — Data released from the bridge-to-transplantation (BTT) arm of the HeartMate II Pivotal trial demonstrate that the device provides effective mechanical circulatory support as a bridge to transplantation for heart failure patients, and that these patients experience a lower number of adverse events and an improved quality of life while being supported by the device.

March 29, 2007 — Israeli scientists have developed a portable electrocardiograph machine that can transmit highly detailed data on heart activity to physicians by mobile phone. The CardioSen'C is considered an advance in portable heart-monitoring devices because it uses many more electrodes to measure heart activity and is equipped to communicate the results instantaneously to a cardiologist.

March 29, 2007 — Access Scientific introduced its Wand All-in-One Micro-Access Safety Introducer at the recent annual meeting of the Society for Interventional Radiology (SIR). The Wand is a unique, proprietary introducer that may provide faster and easier micro-access for all types of vascular access.

The company is preparing to seek FDA 510(k) market clearance for The Wand. The device is protected by patents and patents pending, domestic and international.

March 29, 2007 — At the ACC this week Dr. Nabil Dib, M.D., M.Sc., director of Cardiovascular Cell Therapy at University of California San Diego, reported how 23 patients in an FDA trial were safely transformed from advanced heart failure to recovery.

March 29, 2007 —Data on Abiomed Inc.’s Impella 2.5 were presented at the American College of Cardiology's (ACC) 56th Annual Scientific Sessions by Drs. Krischan D. Sjauw, Maurice Remmelink, Jan Baan, Jr., Rene J. van der Schaaf, Marije M. Vis, Karel T. Koch, Jan G. Tijssen, Jan J. Piek, Robbert J. de Winter, and Jose P. Henriques.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now